Evidence map›Paper›PMID 37736960›Full record

ArticleMethods and protocols2023

Improvement of Targeted Fungi Secondary Metabolite Production Using a Systematic Experimental Design and Chemometrics Analysis.

Lamonielli F Michaliski, Laura P Ióca, Leandro S Oliveira, Camila M Crnkovic, Mirelle Takaki, Vitor F Freire, Roberto G S Berlinck

Abstract read
In one paragraph

Article in Methods and protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lamonielli F MichaliskiInstituto de Química de São Carlos, Universidade de São Paulo, CP 780, São Carlos CEP 13560-970, SP, Brazil.ORCID 0000-0002-6499-6068
Laura P IócaInstituto de Química de São Carlos, Universidade de São Paulo, CP 780, São Carlos CEP 13560-970, SP, Brazil.
Leandro S OliveiraInstituto de Química de São Carlos, Universidade de São Paulo, CP 780, São Carlos CEP 13560-970, SP, Brazil.
Camila M CrnkovicDepartamento de Tecnologia Bioquímico-Farmacêutica, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo CEP 05508-000, SP, Brazil.ORCID 0000-0001-6581-9031
Mirelle TakakiInstituto de Química de São Carlos, Universidade de São Paulo, CP 780, São Carlos CEP 13560-970, SP, Brazil.
Vitor F FreireInstituto de Química de São Carlos, Universidade de São Paulo, CP 780, São Carlos CEP 13560-970, SP, Brazil.ORCID 0000-0001-6565-1830
Roberto G S BerlinckInstituto de Química de São Carlos, Universidade de São Paulo, CP 780, São Carlos CEP 13560-970, SP, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 141464/2017-8Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.372014/2019-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/17721-9
6 · The paper itself

Abstract

Fungi are well-known producers of chemically diverse and biologically active secondary metabolites. However, their production yields through fermentation may hamper structural analysis and biological activity downstream investigations. Herein, a systematic experimental design that varies multiple cultivation parameters, followed by chemometrics analysis on HPLC-UV-MS or UHPLC-HRMS/MS data, is presented to enhance the production yield of fungal natural products. The overall procedure typically requires 3-4 months of work when first developed, and up to 3 months as a routine procedure.

Indexed as

chemometricsfermentation yieldfractional factorial designfungimetabolomicsmicroorganismnatural productssecondary metabolites

Identifiers

PMID37736960
PMCPMC10514814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.